APA (7th ed.) Citation

Aguareles, J., Forné, C., García-Casas, A., Santamaría-Corral, G., Carnevali-Ruiz, D., Sotres-Fernández, G., . . . Guisado-Vasco, P. Influence of anti-Spike protein antibody levels on tocilizumab efficacy in hospitalized patients with severe COVID-19 pneumonia: A post-hoc analysis of the COVACTA trial. BMC.

Chicago Style (17th ed.) Citation

Aguareles, José, Carles Forné, Ana García-Casas, Guillermo Santamaría-Corral, Daniel Carnevali-Ruiz, Gabriel Sotres-Fernández, Javier T. Solera, and Pablo Guisado-Vasco. Influence of Anti-Spike Protein Antibody Levels on Tocilizumab Efficacy in Hospitalized Patients with Severe COVID-19 Pneumonia: A Post-hoc Analysis of the COVACTA Trial. BMC.

MLA (9th ed.) Citation

Aguareles, José, et al. Influence of Anti-Spike Protein Antibody Levels on Tocilizumab Efficacy in Hospitalized Patients with Severe COVID-19 Pneumonia: A Post-hoc Analysis of the COVACTA Trial. BMC.